Corealis Pharma is pleased to attend the OBIO Investment Summit, Canada’s premier health sciences investment event connecting innovators, investors, and industry leaders across the life sciences ecosystem.
CEO David Leroux-Petersen and VP Business Development Patrick Frankham, will be attending to meet with partners, investors, and biotech leaders to discuss collaboration opportunities and Corealis’ end-to-end CDMO services.
Stop by to connect with our team and discover how Corealis turns complex molecules into clinical success stories.
Meet Us There
Stop by to connect with our team and discover how Corealis turns complex molecules into clinical success stories.
